vs

Side-by-side financial comparison of COVENANT LOGISTICS GROUP, INC. (CVLG) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $307.2M, roughly 1.0× COVENANT LOGISTICS GROUP, INC.). COVENANT LOGISTICS GROUP, INC. runs the higher net margin — 1.4% vs -18.2%, a 19.7% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 14.0%).

Covenant Logistics Group, Inc. is an American company focused on truckload shipping. The company is headquartered in Chattanooga, Tennessee, and is publicly traded on the New York Stock Exchange. The company provides temperature controlled trucking, regional delivery, and longhaul team driver delivery.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

CVLG vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.0× larger
MDGL
$321.1M
$307.2M
CVLG
Growing faster (revenue YoY)
MDGL
MDGL
+196.7% gap
MDGL
210.8%
14.0%
CVLG
Higher net margin
CVLG
CVLG
19.7% more per $
CVLG
1.4%
-18.2%
MDGL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CVLG
CVLG
MDGL
MDGL
Revenue
$307.2M
$321.1M
Net Profit
$4.4M
$-58.6M
Gross Margin
Operating Margin
2.0%
-18.6%
Net Margin
1.4%
-18.2%
Revenue YoY
14.0%
210.8%
Net Profit YoY
-32.7%
1.4%
EPS (diluted)
$0.17
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVLG
CVLG
MDGL
MDGL
Q1 26
$307.2M
Q4 25
$295.4M
$321.1M
Q3 25
$296.9M
$287.3M
Q2 25
$302.9M
$212.8M
Q1 25
$269.4M
$137.3M
Q4 24
$277.3M
$103.3M
Q3 24
$287.9M
$62.2M
Q2 24
$287.5M
Net Profit
CVLG
CVLG
MDGL
MDGL
Q1 26
$4.4M
Q4 25
$-58.6M
Q3 25
$9.1M
$-114.2M
Q2 25
$9.8M
$-42.3M
Q1 25
$6.6M
$-73.2M
Q4 24
$-59.4M
Q3 24
$13.0M
$-107.0M
Q2 24
$12.2M
Gross Margin
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Operating Margin
CVLG
CVLG
MDGL
MDGL
Q1 26
2.0%
Q4 25
-8.2%
-18.6%
Q3 25
2.7%
-39.7%
Q2 25
3.8%
-22.2%
Q1 25
2.8%
-57.8%
Q4 24
3.1%
-64.8%
Q3 24
5.6%
-187.1%
Q2 24
5.4%
Net Margin
CVLG
CVLG
MDGL
MDGL
Q1 26
1.4%
Q4 25
-18.2%
Q3 25
3.1%
-39.8%
Q2 25
3.2%
-19.9%
Q1 25
2.4%
-53.4%
Q4 24
-57.5%
Q3 24
4.5%
-172.0%
Q2 24
4.2%
EPS (diluted)
CVLG
CVLG
MDGL
MDGL
Q1 26
$0.17
Q4 25
$-0.68
$-2.55
Q3 25
$0.35
$-5.08
Q2 25
$0.36
$-1.90
Q1 25
$0.24
$-3.32
Q4 24
$0.25
$-2.50
Q3 24
$0.47
$-4.92
Q2 24
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVLG
CVLG
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$407.6M
$602.7M
Total Assets
$1.0B
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
$4.9M
$198.7M
Q3 25
$2.7M
$295.7M
Q2 25
$143.0K
$186.2M
Q1 25
$11.2M
$183.6M
Q4 24
$35.6M
$100.0M
Q3 24
$35.2M
$232.7M
Q2 24
$1.3M
Total Debt
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
$261.7M
$339.9M
Q3 25
$233.3M
$339.8M
Q2 25
$245.8M
$118.4M
Q1 25
$216.3M
$118.0M
Q4 24
$221.6M
$117.6M
Q3 24
$231.4M
$117.1M
Q2 24
$235.0M
Stockholders' Equity
CVLG
CVLG
MDGL
MDGL
Q1 26
$407.6M
Q4 25
$404.0M
$602.7M
Q3 25
$423.7M
$625.7M
Q2 25
$416.9M
$696.0M
Q1 25
$443.6M
$710.6M
Q4 24
$438.3M
$754.4M
Q3 24
$431.6M
$777.2M
Q2 24
$419.4M
Total Assets
CVLG
CVLG
MDGL
MDGL
Q1 26
$1.0B
Q4 25
$1.0B
$1.3B
Q3 25
$1.0B
$1.4B
Q2 25
$1.0B
$1.0B
Q1 25
$980.0M
$996.6M
Q4 24
$997.6M
$1.0B
Q3 24
$1.0B
$1.1B
Q2 24
$995.0M
Debt / Equity
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
0.65×
0.56×
Q3 25
0.55×
0.54×
Q2 25
0.59×
0.17×
Q1 25
0.49×
0.17×
Q4 24
0.51×
0.16×
Q3 24
0.54×
0.15×
Q2 24
0.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVLG
CVLG
MDGL
MDGL
Operating Cash FlowLast quarter
$-133.5M
Free Cash FlowOCF − Capex
$-133.8M
FCF MarginFCF / Revenue
-41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
$25.5M
$-133.5M
Q3 25
$41.4M
$79.8M
Q2 25
$21.9M
$-47.1M
Q1 25
$24.8M
$-88.9M
Q4 24
$21.9M
$-104.5M
Q3 24
$56.9M
$-67.0M
Q2 24
$22.4M
Free Cash Flow
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
$-3.0M
$-133.8M
Q3 25
$-7.8M
$79.0M
Q2 25
$-14.5M
Q1 25
$-8.6M
Q4 24
$464.0K
$-104.7M
Q3 24
$24.3M
$-67.8M
Q2 24
$-28.1M
FCF Margin
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
-1.0%
-41.7%
Q3 25
-2.6%
27.5%
Q2 25
-4.8%
Q1 25
-3.2%
Q4 24
0.2%
-101.3%
Q3 24
8.4%
-109.0%
Q2 24
-9.8%
Capex Intensity
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
9.7%
0.1%
Q3 25
16.6%
0.3%
Q2 25
12.0%
0.0%
Q1 25
12.4%
0.0%
Q4 24
7.7%
0.2%
Q3 24
11.3%
1.3%
Q2 24
17.6%
Cash Conversion
CVLG
CVLG
MDGL
MDGL
Q1 26
Q4 25
Q3 25
4.55×
Q2 25
2.23×
Q1 25
3.78×
Q4 24
Q3 24
4.36×
Q2 24
1.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVLG
CVLG

Freight revenue$281.9M92%
Other$25.2M8%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons